Previous preeclampsia and its association with the future development of cardiovascular diseases: a systematic review and meta-analysis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/191710 |
Resumo: | Preeclampsia is a multifactorial disease. Among these factors, untreated hypertension during pregnancy can result in high morbidity and mortality rates and may also be related to the future development of cardiovascular diseases.Therefore, this systematic review aimed to determine the association of previous preeclampsia with the future development of cardiovascular diseases. Studies on the association between preeclampsia and future cardiovascular diseases published in the last 10 years (2009–2019) were identified from the PubMed/Medline (207 articles), Embase (nine articles), and Cochrane (three articles) databases using the keywords ‘‘preeclampsia’’ and ‘‘future cardiovascular diseases’’, ‘‘preeclampsia’’ and ‘‘future heart attack’’, and ‘‘preeclampsia’’ and ‘‘future cardiac disease’’. After applying the inclusion and exclusion criteria, 15 articles were analyzed by systematic review and meta-analysis according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The meta-analysis and the determination of the quality of the articles were conducted using RevMan software, version 5.3. Statistically significant differences were observed between the control and previous preeclampsia groups with respect to systolic blood pressure (mean difference [MD] 4.32; 95% confidence interval [95%CI] 3.65, 4.99; po0.001), diastolic blood pressure (MD: 2.11; 95%CI: 1.68, 2.55; po0.0001), and insulin level (MD: 2.80; 95% CI: 0.50, 5.11; po0.001). Body mass index (MD: 2.57, 95%CI: 2.06, 3.07; p=0.0001), total cholesterol (MD: 10.39; 95% CI: 8.91, 11.87; p=0.0001), HDL (MD: 2.83; 95%CI: 2.20, 3.46; p=0.0001), and LDL (MD: 1.77; 95%CI: 0.42, 3.13; p=0.0001) also differed significantly between groups. Thus, the results of the present study showed that women with a history of preeclampsia were more likely to develop cardiovascular disease. |
id |
USP-19_07f8dbcbe7b130e177dea612626a920e |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/191710 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Previous preeclampsia and its association with the future development of cardiovascular diseases: a systematic review and meta-analysisPreeclampsiaFuture Cardiovascular DiseasesSystematic ReviewMeta-AnalysisPreeclampsia is a multifactorial disease. Among these factors, untreated hypertension during pregnancy can result in high morbidity and mortality rates and may also be related to the future development of cardiovascular diseases.Therefore, this systematic review aimed to determine the association of previous preeclampsia with the future development of cardiovascular diseases. Studies on the association between preeclampsia and future cardiovascular diseases published in the last 10 years (2009–2019) were identified from the PubMed/Medline (207 articles), Embase (nine articles), and Cochrane (three articles) databases using the keywords ‘‘preeclampsia’’ and ‘‘future cardiovascular diseases’’, ‘‘preeclampsia’’ and ‘‘future heart attack’’, and ‘‘preeclampsia’’ and ‘‘future cardiac disease’’. After applying the inclusion and exclusion criteria, 15 articles were analyzed by systematic review and meta-analysis according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The meta-analysis and the determination of the quality of the articles were conducted using RevMan software, version 5.3. Statistically significant differences were observed between the control and previous preeclampsia groups with respect to systolic blood pressure (mean difference [MD] 4.32; 95% confidence interval [95%CI] 3.65, 4.99; po0.001), diastolic blood pressure (MD: 2.11; 95%CI: 1.68, 2.55; po0.0001), and insulin level (MD: 2.80; 95% CI: 0.50, 5.11; po0.001). Body mass index (MD: 2.57, 95%CI: 2.06, 3.07; p=0.0001), total cholesterol (MD: 10.39; 95% CI: 8.91, 11.87; p=0.0001), HDL (MD: 2.83; 95%CI: 2.20, 3.46; p=0.0001), and LDL (MD: 1.77; 95%CI: 0.42, 3.13; p=0.0001) also differed significantly between groups. Thus, the results of the present study showed that women with a history of preeclampsia were more likely to develop cardiovascular disease.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2021-11-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/19171010.6061/clinics/2021/e1999Clinics; Vol. 76 (2021); e1999Clinics; v. 76 (2021); e1999Clinics; Vol. 76 (2021); e19991980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/191710/176635Copyright (c) 2021 Clinicsinfo:eu-repo/semantics/openAccessVeiga, Eduardo Carvalho de Arruda Rocha, Paulo Ricardo Higassiaraguti Caviola, Leonardo L. Cardoso, Viviane Cunha Costa, Fabricio da Silva Saraiva, Maria da Conceição Pereira Barbieri, Marco Antonio Bettiol, Heloisa Cavalli, Ricardo Carvalho 2023-07-06T13:04:09Zoai:revistas.usp.br:article/191710Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2023-07-06T13:04:09Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Previous preeclampsia and its association with the future development of cardiovascular diseases: a systematic review and meta-analysis |
title |
Previous preeclampsia and its association with the future development of cardiovascular diseases: a systematic review and meta-analysis |
spellingShingle |
Previous preeclampsia and its association with the future development of cardiovascular diseases: a systematic review and meta-analysis Veiga, Eduardo Carvalho de Arruda Preeclampsia Future Cardiovascular Diseases Systematic Review Meta-Analysis |
title_short |
Previous preeclampsia and its association with the future development of cardiovascular diseases: a systematic review and meta-analysis |
title_full |
Previous preeclampsia and its association with the future development of cardiovascular diseases: a systematic review and meta-analysis |
title_fullStr |
Previous preeclampsia and its association with the future development of cardiovascular diseases: a systematic review and meta-analysis |
title_full_unstemmed |
Previous preeclampsia and its association with the future development of cardiovascular diseases: a systematic review and meta-analysis |
title_sort |
Previous preeclampsia and its association with the future development of cardiovascular diseases: a systematic review and meta-analysis |
author |
Veiga, Eduardo Carvalho de Arruda |
author_facet |
Veiga, Eduardo Carvalho de Arruda Rocha, Paulo Ricardo Higassiaraguti Caviola, Leonardo L. Cardoso, Viviane Cunha Costa, Fabricio da Silva Saraiva, Maria da Conceição Pereira Barbieri, Marco Antonio Bettiol, Heloisa Cavalli, Ricardo Carvalho |
author_role |
author |
author2 |
Rocha, Paulo Ricardo Higassiaraguti Caviola, Leonardo L. Cardoso, Viviane Cunha Costa, Fabricio da Silva Saraiva, Maria da Conceição Pereira Barbieri, Marco Antonio Bettiol, Heloisa Cavalli, Ricardo Carvalho |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Veiga, Eduardo Carvalho de Arruda Rocha, Paulo Ricardo Higassiaraguti Caviola, Leonardo L. Cardoso, Viviane Cunha Costa, Fabricio da Silva Saraiva, Maria da Conceição Pereira Barbieri, Marco Antonio Bettiol, Heloisa Cavalli, Ricardo Carvalho |
dc.subject.por.fl_str_mv |
Preeclampsia Future Cardiovascular Diseases Systematic Review Meta-Analysis |
topic |
Preeclampsia Future Cardiovascular Diseases Systematic Review Meta-Analysis |
description |
Preeclampsia is a multifactorial disease. Among these factors, untreated hypertension during pregnancy can result in high morbidity and mortality rates and may also be related to the future development of cardiovascular diseases.Therefore, this systematic review aimed to determine the association of previous preeclampsia with the future development of cardiovascular diseases. Studies on the association between preeclampsia and future cardiovascular diseases published in the last 10 years (2009–2019) were identified from the PubMed/Medline (207 articles), Embase (nine articles), and Cochrane (three articles) databases using the keywords ‘‘preeclampsia’’ and ‘‘future cardiovascular diseases’’, ‘‘preeclampsia’’ and ‘‘future heart attack’’, and ‘‘preeclampsia’’ and ‘‘future cardiac disease’’. After applying the inclusion and exclusion criteria, 15 articles were analyzed by systematic review and meta-analysis according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The meta-analysis and the determination of the quality of the articles were conducted using RevMan software, version 5.3. Statistically significant differences were observed between the control and previous preeclampsia groups with respect to systolic blood pressure (mean difference [MD] 4.32; 95% confidence interval [95%CI] 3.65, 4.99; po0.001), diastolic blood pressure (MD: 2.11; 95%CI: 1.68, 2.55; po0.0001), and insulin level (MD: 2.80; 95% CI: 0.50, 5.11; po0.001). Body mass index (MD: 2.57, 95%CI: 2.06, 3.07; p=0.0001), total cholesterol (MD: 10.39; 95% CI: 8.91, 11.87; p=0.0001), HDL (MD: 2.83; 95%CI: 2.20, 3.46; p=0.0001), and LDL (MD: 1.77; 95%CI: 0.42, 3.13; p=0.0001) also differed significantly between groups. Thus, the results of the present study showed that women with a history of preeclampsia were more likely to develop cardiovascular disease. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-11-09 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/191710 10.6061/clinics/2021/e1999 |
url |
https://www.revistas.usp.br/clinics/article/view/191710 |
identifier_str_mv |
10.6061/clinics/2021/e1999 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/191710/176635 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Clinics info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 Clinics |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 76 (2021); e1999 Clinics; v. 76 (2021); e1999 Clinics; Vol. 76 (2021); e1999 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222765571112960 |